KONAKION Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Konakion, and what generic alternatives are available?
Konakion is a drug marketed by Roche and is included in one NDA.
The generic ingredient in KONAKION is phytonadione. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Konakion
A generic version of KONAKION was approved as phytonadione by AMNEAL PHARMS CO on May 11th, 2018.
Summary for KONAKION
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 103 |
Patent Applications: | 3,627 |
Formulation / Manufacturing: | see details |
DailyMed Link: | KONAKION at DailyMed |
US Patents and Regulatory Information for KONAKION
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | KONAKION | phytonadione | INJECTABLE;INJECTION | 011745-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche | KONAKION | phytonadione | INJECTABLE;INJECTION | 011745-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |